Developmental and Epileptic Encephalopathy clinical trials at UCSF

1 research study open to eligible people

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
open to eligible people ages 12-65
The objective of this study is to assess the safety, tolerability, efficacy, and pharmacokinetics of adjunctive therapy of LP352 in adults and adolescents with developmental and epileptic encephalopathies.
San Francisco, California and other locations

Last updated: November 14, 2022